Zhang and Xiao (IMAGE)

Rice University

Zhang and Xiao

Caption

From left, Baylor College of Medicine biologist Xiang Zhang and Rice University chemist Han Xiao have received $2.3 million from the Department of Defense to continue development of a promising new “glyco-immune” checkpoint inhibitor, a drug that would train the immune systems of breast cancer survivors to target and kill metastatic bone cancer.

Credit

Credit: Jeff Fitlow/Rice University

Usage Restrictions

Must credit: Jeff Fitlow/Rice University

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.